SNOMED International’s Global Patient Set: Navigating International Patient Care and Interoperability
LONDON, April 17, 2019 (GLOBE NEWSWIRE) -- At SNOMED International’s April Business Meeting held in London last week, the organization announced to its Community of Practice the planned release of a Global Patient Set built from its globally recognized SNOMED CT clinical terminology standard.
SNOMED International will release the Global Patient Set, or GPS, to support the cross border movement of information, and ultimately health system interoperability. Once released, the GPS, a controlled list of existing SNOMED CT unique concept identifiers, single descriptions and reference sets, will be available to all interested parties at no cost to users.
The Chair of the organization’s General Assembly, Lies van Gennip, is delighted to share with health systems and industry what the Global Patient Set provides to Members and non-Members alike. “The Global Patient Set enables easier specification of EHR requirements, e.g. a patient summary, and results in improved interoperability. The Set will also offer non-Members considering SNOMED CT use a mechanism for greater insight into the product and its value without requiring initial investment.”
CEO, Don Sweete, emphasizes that the release of the GPS serves as a stepping stone to leverage the true value of SNOMED CT’s polyhierarchical design. “An innovative offering, it is worth noting that the Global Patient Set offers a limited function of SNOMED CT. Providing a flat list of existing concepts and reference sets, the GPS is positioned to support cross border interoperability and enhanced digital maturity as users move towards decision support and full analytics capabilities in their respective strategies,” said Sweete in his discussions with the SNOMED CT Community of Practice last week.
Chief among its advantages, SNOMED International Members benefit from a terminology that enables interoperability, reduced clinical risk, large scale public health reporting and research, along with a wealth of organization resources including education, tooling, creation of national extensions, representation on governance bodies, and dedicated on-boarding and user support.
Over the coming months, SNOMED International will formalize the steps and due diligence required to make the GPS offering available for release September 1, 2019. Throughout this period, SNOMED International will continue to define the Global Patient Set, from content through to its release and maintenance approach. Refer to SNOMED International’s Global Patient Set resources to learn more as this initiative progresses. Subscribe with the organization’s news service to keep up to date on developments as they occur.
For additional information, contact email@example.com .
About SNOMED International
SNOMED International is a not-for-profit organization that owns and develops SNOMED CT, the world's most comprehensive healthcare terminology product. We play an essential role in improving the health of humankind by determining standards for a codified language that represents groups of clinical terms. This enables healthcare information to be exchanged globally for the benefit of patients and other stakeholders. We are committed to the rigorous evolution of our products and services, to deliver continuous innovation for the global healthcare community. SNOMED International is the trading name of the International Health Terminology Standards Development Organisation.
Kelly Kuru, Executive Lead, Communications
Telephone: +1-416-566-8725 (Canada)
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Globenewswire
Euro Manganese Inc.22.5.2019 23:11:07 CEST | Pressemeddelelse
Euro Manganese Provides Operational Update for the Chvaletice Manganese Project
Tricentis22.5.2019 17:03:19 CEST | Pressemeddelelse
Tricentis Disrupts RPA Market with Resilient Model-Based Automation
Abeona Therapeutics Inc.21.5.2019 14:03:09 CEST | Pressemeddelelse
Abeona Therapeutics Announces FDA Clearance of Investigational New Drug Application for ABO-202 Gene Therapy in CLN1 Disease
Invivoscribe, Inc.21.5.2019 12:02:33 CEST | Pressemeddelelse
Invivoscribe Expanding Clinical Laboratory Network Space and Testing Capabilities in San Diego, Germany, Japan, and China. Offering Comprehensive Standardized Testing for All Hematologic Malignancies
GridGain Systems21.5.2019 09:02:54 CEST | Pressemeddelelse
GridGain Joins Cloud Native Computing Foundation
IMImobile21.5.2019 09:02:54 CEST | Pressemeddelelse
Telia Norway signs partner agreement with IMImobile for Enterprise cPaaS offering
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum